» Articles » PMID: 28384085

An Overview of Research and Evaluation Designs for Dissemination and Implementation

Abstract

The wide variety of dissemination and implementation designs now being used to evaluate and improve health systems and outcomes warrants review of the scope, features, and limitations of these designs. This article is one product of a design workgroup that was formed in 2013 by the National Institutes of Health to address dissemination and implementation research, and whose members represented diverse methodologic backgrounds, content focus areas, and health sectors. These experts integrated their collective knowledge on dissemination and implementation designs with searches of published evaluations strategies. This article emphasizes randomized and nonrandomized designs for the traditional translational research continuum or pipeline, which builds on existing efficacy and effectiveness trials to examine how one or more evidence-based clinical/prevention interventions are adopted, scaled up, and sustained in community or service delivery systems. We also mention other designs, including hybrid designs that combine effectiveness and implementation research, quality improvement designs for local knowledge, and designs that use simulation modeling.

Citing Articles

Rollout trial designs in implementation research are often necessary and sometimes preferred.

Simon G, Garner B, Smith J, Wyman P, Matson T, Chin-Purcell L Implement Sci. 2025; 20(1):11.

PMID: 39994781 PMC: 11849316. DOI: 10.1186/s13012-025-01422-x.


Surveying the Literature on Implementation Determinants and Strategies for HIV Structural Interventions: A Systematic Review Protocol.

Zamantakis A, Chandra S, Donoso V, Paton R, Powers A, Mustanski B medRxiv. 2025; .

PMID: 39802754 PMC: 11722455. DOI: 10.1101/2025.01.02.25319901.


A Protocol for a Mixed Methods, Single-Arm, Hybrid Effectiveness-Implementation Trial Evaluating a 12-week Yoga Intervention Delivered by Videoconference for Young Adults Diagnosed With Cancer.

Wurz A, McLaughlin E, Janzen A, Cripps H, Huang L, Molina H Glob Adv Integr Med Health. 2024; 13:27536130241305130.

PMID: 39717073 PMC: 11664516. DOI: 10.1177/27536130241305130.


Strategies for enhancing the implementation of school-based policies or practices targeting diet, physical activity, obesity, tobacco or alcohol use.

Lee D, OBrien K, McCrabb S, Wolfenden L, Tzelepis F, Barnes C Cochrane Database Syst Rev. 2024; 12:CD011677.

PMID: 39665378 PMC: 11635919. DOI: 10.1002/14651858.CD011677.pub4.


Improving screening, brief intervention and referral to treatment for unhealthy alcohol use in diverse, low-resourced primary care clinics.

Davis M, Coury J, Sanchez V, Kenzie E, Larson J, Barnes C BMC Health Serv Res. 2024; 24(1):1384.

PMID: 39533319 PMC: 11556179. DOI: 10.1186/s12913-024-11870-8.


References
1.
Cross W, West J, Wyman P, Schmeelk-Cone K, Xia Y, Tu X . Observational measures of implementer fidelity for a school-based preventive intervention: development, reliability, and validity. Prev Sci. 2014; 16(1):122-32. PMC: 4199927. DOI: 10.1007/s11121-014-0488-9. View

2.
Katz D, Vander Weg M, Fu S, Prochazka A, Grant K, Buchanan L . A before-after implementation trial of smoking cessation guidelines in hospitalized veterans. Implement Sci. 2009; 4:58. PMC: 2753631. DOI: 10.1186/1748-5908-4-58. View

3.
Wyman P, Henry D, Knoblauch S, Brown C . Designs for Testing Group-Based Interventions with Limited Numbers of Social Units: The Dynamic Wait-Listed and Regression Point Displacement Designs. Prev Sci. 2014; 16(7):956-66. PMC: 4458455. DOI: 10.1007/s11121-014-0535-6. View

4.
Collins L, Murphy S, Bierman K . A conceptual framework for adaptive preventive interventions. Prev Sci. 2004; 5(3):185-96. PMC: 3544191. DOI: 10.1023/b:prev.0000037641.26017.00. View

5.
Brown C, Wang W, Kellam S, Muthen B, Petras H, Toyinbo P . Methods for testing theory and evaluating impact in randomized field trials: intent-to-treat analyses for integrating the perspectives of person, place, and time. Drug Alcohol Depend. 2008; 95 Suppl 1:S74-S104. PMC: 2560173. DOI: 10.1016/j.drugalcdep.2007.11.013. View